{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:39:43Z","timestamp":1769575183165,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.gene.2014.08.009","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T20:45:37Z","timestamp":1407271537000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The TLR3, PI3K, survin, FasL, and Fas genes as major risk factors of occurrence and development of cervical cancer disease"],"prefix":"10.1016","volume":"550","author":[{"given":"Hui Na","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Rong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2014.08.009_bb0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0264-410X(02)00599-6","article-title":"Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly[I]:poly[C(12)U] (Ampligen R)","volume":"21","author":"Adams","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.gene.2014.08.009_bb0010","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.200425801","article-title":"Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4","volume":"35","author":"Aksoy","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.gene.2014.08.009_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2014.08.009_bb0020","series-title":"Cancer Facts & Figures 2010","author":"American Cancer Society","year":"2010"},{"key":"10.1016\/j.gene.2014.08.009_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1048-891X.2005.15002.x","article-title":"Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplasia","volume":"15","author":"Bell","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gene.2014.08.009_bb0030","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/377630a0","article-title":"A role for CD95 ligand in preventing graft rejection","volume":"377","author":"Bellgrau","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.08.009_bb0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10555-010-9261-0","article-title":"The phosphatidyl inositol 3-kinase\/AKT signaling pathway in breast cancer","volume":"29","author":"Castaneda","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.gene.2014.08.009_bb0040","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1038\/sj.onc.1210560","article-title":"Regulation of mitochondrial Smac\/DIABLO-selective release by survivin","volume":"26","author":"Ceballos-Cancino","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2014.08.009_bb0045","doi-asserted-by":"crossref","first-page":"34087","DOI":"10.1074\/jbc.C400236200","article-title":"An IAP\u2013IAP complex inhibits apoptosis","volume":"279","author":"Dohi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2014.08.009_bb0050","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1462-5822.2006.00713.x","article-title":"Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence","volume":"8","author":"Ehrhardt","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.gene.2014.08.009_bb0055","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.11674","article-title":"Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers","volume":"98","author":"Follen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.gene.2014.08.009_bb0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1471-4906(03)00139-X","article-title":"PI3K and negative regulation of TLR signaling","volume":"24","author":"Fukao","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.gene.2014.08.009_bb0065","first-page":"2462","article-title":"Regulation of microtubule stability and mitotic progression by survivin","volume":"62","author":"Giodini","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2014.08.009_bb0070","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0006-2952(00)00481-0","article-title":"Caspase-8 activation independent of CD95\/CD95-L interaction during paclitaxel-Induced apoptosis in human colon cancer cells (HT29-D4)","volume":"60","author":"Goncalves","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2014.08.009_bb0075","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.08.009_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2004.12.007","article-title":"LY294002 inhibits LPS induced NO production through a inhibition of NF-jB activation: independent mechanism of phosphatidylinositol 3-kinase","volume":"99","author":"Kim","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.gene.2014.08.009_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1242\/jcs.01610","article-title":"Death receptor signaling","volume":"118","author":"Lavrik","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.gene.2014.08.009_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.onc.1206978","article-title":"Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells","volume":"23","author":"Liu","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2014.08.009_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-2776(08)60672-0","article-title":"Fas and Fas ligand: a death factor and its receptor","volume":"57","author":"Nagata","year":"1994","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.gene.2014.08.009_bb0095","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.08.009_bb0105","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1016\/S0021-9258(19)50076-X","article-title":"Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor\/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen","volume":"267","author":"Oehm","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2014.08.009_bb0110","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.4049\/jimmunol.161.12.6947","article-title":"Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production","volume":"161","author":"Salh","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2014.08.009_bb0115","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/01.ATV.0000143096.15099.ce","article-title":"PI3K\u2013Akt pathway suppresses coagulation and inflammation in endotoxemic mice","volume":"24","author":"Schabbauer","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2014.08.009_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri1996","article-title":"Steady-state and inflammatory dendritic-cell development","volume":"7","author":"Shortman","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.gene.2014.08.009_bb0125","doi-asserted-by":"crossref","first-page":"23130","DOI":"10.1074\/jbc.M300957200","article-title":"Direct interaction between survivin and Smac\/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis","volume":"278","author":"Song","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2014.08.009_bb0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.179.3.873","article-title":"Purification and characterization of the Fas\u2013ligand that induces apoptosis","volume":"179","author":"Suda","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2014.08.009_bb0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/BF01709367","article-title":"Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:poly-C12U in the treatment of HIV infection","volume":"15","author":"Thompson","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.gene.2014.08.009_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cellsig.2003.08.007","article-title":"Death receptor-induced cell killing","volume":"16","author":"Thorburn","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.gene.2014.08.009_bb0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00262-005-0056-z","article-title":"A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients","volume":"55","author":"Trakatelli","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.gene.2014.08.009_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.2787530","article-title":"Monoclonal antibody-mediated tumor regression by induction of apoptosis","volume":"245","author":"Trauth","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.08.009_bb0160","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"Vlahos","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2014.08.009_bb0170","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.169.5.1747","article-title":"A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor","volume":"169","author":"Yonehara","year":"1989","journal-title":"J. Exp. Med."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914009068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914009068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T18:56:21Z","timestamp":1689447381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111914009068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0378111914009068"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2014.08.009","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TLR3, PI3K, survin, FasL, and Fas genes as major risk factors of occurrence and development of cervical cancer disease","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2014.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}